{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T22:53:48Z","timestamp":1756076028552,"version":"3.41.2"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002551","name":"Seoul National University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002551","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["por-journal.com"],"crossmark-restriction":true},"short-container-title":["Pathol. Oncol. Res."],"abstract":"<jats:p><jats:bold>Background\/Aims:<\/jats:bold> Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ) activation has been implicated in hepatocarcinogenesis and hepatic progenitor cell differentiation, and hypoxia has been shown to induce nuclear translocation of YAP in cancer cells. Here, we aimed to investigate the relationship between hypoxia, YAP and TAZ expression and stemness-related marker expression in human hepatocellular carcinomas (HCCs) and its clinical implications.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Immunohistochemical stains were performed on tissue microarrays from 305 surgically resected HCCs, and the expression status of YAP and TAZ were correlated with CAIX, stemness markers (K19, EpCAM) and epithelial-mesenchymal transition (EMT)-related markers (uPAR, ezrin). The clinicopathological significance of YAP\/TAZ expression was analyzed with relation to CAIX expression status.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> YAP and TAZ expression were seen in 13.4 and 4.3% of HCCs, respectively. YAP\/TAZ-positive HCCs frequently demonstrated higher serum AFP levels, microvascular invasion, advanced tumor stage, increased proliferative activity and expression of stemness- and EMT-related markers, CAIX, p53 and Smad2\/3 (<jats:italic>p<\/jats:italic> &amp;lt; 0.05, all). Interestingly, YAP\/TAZ-positivity was associated with microvascular invasion, higher serum AFP levels, stemness and EMT-related marker expression only in tumors expressing CAIX (<jats:italic>p<\/jats:italic> &amp;lt; 0.05, all), while these associations were not seen in CAIX-negative HCCs.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> YAP\/TAZ expression is associated with vascular invasion, stemness and EMT in HCCs with hypoxia marker expression. The effect of Hippo signaling pathway deregulation in HCC may depend on the presence or absence of a hypoxic microenvironment, and hypoxia marker expression status should be taken into account when considering the use of YAP\/TAZ as markers of aggressive biologic behavior in HCC.<\/jats:p>","DOI":"10.3389\/pore.2021.604600","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T05:23:46Z","timestamp":1614576226000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["The Clinicopathological Significance of YAP\/TAZ Expression in Hepatocellular Carcinoma with Relation to Hypoxia and Stemness"],"prefix":"10.3389","volume":"27","author":[{"given":"Hyunjin","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangkyu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiryang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyejung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Eun","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soomin","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Nyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haeryoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1002\/hep.24559","article-title":"Human hepatocellular carcinomas with \u201cStemness\u201d-related marker expression: keratin 19 expression and a poor prognosis","volume":"54","author":"Kim","year":"","journal-title":"Hepatology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/hep.21467","article-title":"Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets","volume":"45","author":"Boyault","year":"","journal-title":"Hepatology."},{"key":"B3","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jhep.2017.05.014","article-title":"Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification","volume":"67","author":"Calderaro","year":"","journal-title":"J Hepatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"7385","DOI":"10.1158\/0008-5472.CAN-09-1089","article-title":"Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma","volume":"69","author":"Hoshida","year":"","journal-title":"Cancer Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.ceb.2008.10.001","article-title":"The Hippo-YAP pathway: new connections between regulation of organ size and cancer","volume":"20","author":"Zhao","year":"","journal-title":"Curr Opin Cell Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1101\/gad.197582.112","article-title":"Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs)","volume":"26","author":"Mo","year":"","journal-title":"Genes Dev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nrd4161","article-title":"The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment","volume":"13","author":"Johnson","year":"","journal-title":"Nat Rev Drug Discov."},{"key":"B8","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.cell.2015.10.044","article-title":"Hippo pathway in organ size control, tissue homeostasis, and cancer","volume":"163","author":"Yu","year":"","journal-title":"Cell."},{"key":"B9","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2009.09.026","article-title":"Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene","volume":"16","author":"Zhou","year":"","journal-title":"Cancer Cell."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1158\/1078-0432.CCR-10-2467","article-title":"Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis","volume":"17","author":"Kang","year":"","journal-title":"Clin Cancer.Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"638","DOI":"10.3390\/ijms20030638","article-title":"YAP and TAZ heterogeneity in primary liver cancer: an analysis of its prognostic and diagnostic role","volume":"20","author":"Van Haele","year":"","journal-title":"Int J Mol Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e65539","DOI":"10.1371\/journal.pone.0065539","article-title":"Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells","volume":"8","author":"Wang","year":"","journal-title":"PLoS One."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/j.1349-7006.2010.01511.x","article-title":"Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer","volume":"101","author":"Wang","year":"","journal-title":"Cancer Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.1002\/cncr.24495","article-title":"Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma","volume":"115","author":"Xu","year":"","journal-title":"Cancer."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e75449","DOI":"10.1371\/journal.pone.0075449","article-title":"Increased expression of Yes-associated protein 1 in hepatocellular carcinoma with stemness and combined hepatocellular-cholangiocarcinoma","volume":"8","author":"Kim","year":"","journal-title":"PLoS One."},{"key":"B16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10555-007-9055-1","article-title":"Hypoxia in cancer: significance and impact on clinical outcome","volume":"26","author":"Vaupel","year":"","journal-title":"Cancer Metastasis Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.18632\/oncotarget.422","article-title":"Recent developments in targeting carbonic anhydrase IX for cancer therapeutics","volume":"3","author":"McDonald","year":"","journal-title":"Oncotarget."},{"key":"B18","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrc1187nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"","journal-title":"Nat Rev Cancer."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/modpathol.2016.111","article-title":"Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization","volume":"29","author":"Rhee","year":"","journal-title":"Mod Pathol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1010428317691684","DOI":"10.1177\/1010428317691684","article-title":"Hypoxia induces oncogene yes-associated protein 1 nuclear translocation to promote pancreatic ductal adenocarcinoma invasion via epithelial-mesenchymal transition","volume":"39","author":"Wei","year":"","journal-title":"Tumour Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4132\/jptm.2017.11.13","article-title":"The clinicopathological and prognostic significance of the gross classification of hepatocellular carcinoma","volume":"52","author":"Lee","year":"","journal-title":"J Pathol Transl Med."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000003781","article-title":"Subclassification of microscopic vascular invasion in hepatocellular carcinoma","author":"Kang","year":"","journal-title":"Ann Surg."},{"key":"B23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.abb.2014.07.024","article-title":"Hypoxic conditions differentially regulate TAZ and YAP in cancer cells","volume":"562","author":"Yan","year":"","journal-title":"Arch Biochem Biophys."},{"key":"B24","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jhep.2018.05.008","article-title":"Liver regeneration requires Yap1-TGFbeta-dependent epithelial-mesenchymal transition in hepatocytes","volume":"69","author":"Oh","year":"","journal-title":"J Hepatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1002\/hep.25570","article-title":"A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and epithelial-mesenchymal transition","volume":"55","author":"Seok","year":"","journal-title":"Hepatology."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1002\/jcb.25117","article-title":"Functional and clinical evidence that TAZ is a candidate oncogene in hepatocellular carcinoma","volume":"116","author":"Guo","year":"","journal-title":"J Cell Biochem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1186\/s12885-017-3431-1","article-title":"The correlation between poor prognosis and increased yes-associated protein 1 expression in keratin 19 expressing hepatocellular carcinomas and cholangiocarcinomas","volume":"17","author":"Lee","year":"","journal-title":"BMC Cancer."},{"key":"B28","doi-asserted-by":"publisher","first-page":"S610","DOI":"10.1245\/s10434-014-3715-5","article-title":"Cytoplasmic YAP expression is associated with prolonged survival in patients with lung adenocarcinomas and epidermal growth factor receptor tyrosine kinase inhibitor treatment","volume":"21","author":"Sun","year":"","journal-title":"Ann Surg Oncol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/jcp.29967","article-title":"The Hippo in the room: targeting the Hippo signalling pathway for osteosarcoma therapies","volume":"236","author":"Rothzerg","year":"","journal-title":"J Cell Physiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.jhep.2014.06.033","article-title":"YAP activation is an early event and a potential therapeutic target in liver cancer development","volume":"61","author":"Perra","year":"","journal-title":"J Hepatol."}],"container-title":["Pathology and Oncology Research"],"original-title":[],"link":[{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2021.604600\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T09:36:25Z","timestamp":1626168985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2021.604600\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":30,"alternative-id":["10.3389\/pore.2021.604600"],"URL":"https:\/\/doi.org\/10.3389\/pore.2021.604600","relation":{},"ISSN":["1532-2807"],"issn-type":[{"type":"electronic","value":"1532-2807"}],"subject":[],"published":{"date-parts":[[2021,3,1]]},"article-number":"604600"}}